Mathias Linnerbauer

14PUBLICATIONS
95CO-AUTHORS
Immunogenetics (incl. genetic immunology)Central nervous systemNeurology and neuromuscular diseasesCellular nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 04, 2026
SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment response.

Johannes Lang, Mathias Linnerbauer, Jeanne Cuny

|Jun 19, 2025
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation.

Lena Lößlein, Mathias Linnerbauer, Finnja Zuber

|Mar 27, 2024
Gut-Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond.

Julia Zißler, Veit Rothhammer, Mathias Linnerbauer

|Feb 26, 2024
The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology.

Mathias Linnerbauer, Lena Lößlein, Oliver Vandrey

|Aug 11, 2023
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.

Thanos Tsaktanis, Mathias Linnerbauer, Lena Lößlein

|Aug 09, 2023
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells.

Liliana M Sanmarco, Joseph M Rone, Carolina M Polonio

Pageof 3